Manipulation of regulatory genes reveals complexity and fidelity in hormaomycin biosynthesis

Chem Biol. 2013 Jun 20;20(6):839-46. doi: 10.1016/j.chembiol.2013.04.018.

Abstract

Hormaomycin (HRM) is a structurally remarkable peptide produced by Streptomyces griseoflavus W-384 that acts as a Streptomyces signaling metabolite and exhibits potent antibiotic activity against coryneform actinomycetes. HRM biosynthetic studies have been hampered by inconsistent and low production. To enhance fermentation titers, the role of its cluster-encoded regulatory genes was investigated. Extra copies of the putative regulators hrmA and hrmB were introduced into the wild-type strain, resulting in an increase of HRM production and its analogs up to 135-fold. For the HrmB overproducer, six bioactive analogs were isolated and characterized. This study demonstrates that HrmA and HrmB are positive regulators in HRM biosynthesis. A third gene, hrmH, was identified as encoding a protein capable of shifting the metabolic profile of HRM and its derivatives. Its manipulation resulted in the generation of an additional HRM analog.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / biosynthesis
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Arthrobacter / drug effects
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Depsipeptides / biosynthesis*
  • Depsipeptides / chemistry
  • Depsipeptides / pharmacology
  • Microbial Sensitivity Tests
  • Multigene Family
  • Streptomyces / genetics
  • Streptomyces / metabolism

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Depsipeptides
  • hormaomycin